medigraphic.com
SPANISH

Medicina Crítica

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • Policies
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2000, Number 3

<< Back Next >>

Med Crit 2000; 14 (3)

Massive blood transfusion in shock patients after cardiotomy supported with ventricular system

Arévalo ES, Bello CJA, Escobedo FD, Durán ÓA, Rodríguez RM, Soto ÁLB
Full text How to cite this article

Language: Spanish
References: 9
Page: 97-101
PDF size: 137.72 Kb.


Key words:

Massive transfussion, shock, cardiotomy, ventricular-assist devices, morbility, mortality surgical ICU.

ABSTRACT

Objective: To report the incidence of massive transfusion in postcardiotomy shock in patients supported with ventricular-assist devices (VAD).
Design: Retrospective study. Setting: Surgical ICU (SICU) of a tertiary care hospital of Monterrey, Mexico.
Patients: All the patients with VAD admitted to the SICU during five years were enrolled.
Interventions: None.
Measurements and main results: Eight VAD patients (mean age 47.1 ± 10.3 yrs) were evaluated. VAD supportwas 5.37 ±, 2.38 days, ICU stay 9.75 ± 2.38 days and mortality rate 75%. Two patients required massive transfusion and six were supported with VAD plus intraaortic ballon counterpulsation. Multiple organ failure (SOFA score) was observed in seven patients: one patient had 6 failures, three 5, two 2, one 4 and one 1; coagulation disorders was the main failure.
Conclusion: The morbility and mortality rate are very high in VAD patients with shock postcardiotomy.



REFERENCES

  1. Frazier OH. New technologies in the treatment of severe cardiac failure: The Texas Heart Institute experience. Ann Thorac Surg 1995;59:S31-S38.

  2. Müller J, Wallukat G, Weng YG et al. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation 1997;96:542-549.

  3. Dipla K, Mattiello JA, Jeevanandam V, Houser SR, Margulies KB. Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure. Circulation 1998;97:2316-2322.

  4. Pennington DG, McBride LR, Kanter KR, Swartz MT, Lagunoff D et al. Effect of perioperative myocardial infarction on survival of postcardiotomy patients supportted with ventricular-assist devices. Circulation 1988;78(Suppl III)110-115.

  5. Guyton RA, Schonberger JPAM, Everts PAM, Jett K, Gray LA et al. Postcardiotomy shock: clinical evaluation of the BVS 5000 biventricular support system. Ann Thorac Surg 1993;56:346-356.

  6. Brister SJ, Shragge BW. Mechanical assistance of the failing heart. Chapter In principles of critical care. Jesse B Hall. New York 1992;28:366-372.

  7. Deisseroth AB, Wallerstein RO. Grupos sanguíneos, tipificación de tejidos y transfusiones de productos de la sangre.In Kelley WN, editor. Medicina Interna. Editorial Médica Panamericana 1992:1331-1336.

  8. Harrigan C, Lucas CE, Ledgerwood AM, Walz DA, Mammen EF. Serial changes in primary hemostasis after massive transfusion. Surgery 1985; 98(4): 836-44.

  9. Vincent JL, De Mendonca A, Cantraine F, Moreno R,Takala J et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: Results of a multicenter, prospective study. Crit Care Med 1998; 26 11: 1793-1800.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Med Crit. 2000;14